A

Aldeyra Therapeutics

D
ALDX
USD
-0.075
(-1.3863%)
Market Closed
14,324.00
Volume
-0.99
EPS
-
Div Yield
-8.335938
P/E
317,013,974.59
Market Cap
Today
-1.1121%
1 Week
1.813%
1 Month
1.042%
6 Months
28.091%
12 Months
92.599%
Year To Date
52.211%
All Time
0%

Title:
Aldeyra Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
Do you need help or have a question?